Abstract
Alzheimer's disease is the most common type of neurodegenerative disease where amyloid-β (Aβ) peptide aggregates to amyloid fibers that accumulate as plaques in the human brain. Recent in vitro results demonstrated that Aβ aggregation can be inhibited by certain cell-penetrating peptides (CPPs) containing a signal sequence NCAM1 for secretion and a short sequence from an amyloidogenic polypeptide (PrP or Aβ).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
